| Name | Title | Contact Details |
|---|
Western States Equipment Company, known as Western States Cat, is a prominent heavy equipment dealer and service provider in the Northwest U.S. Established in 1933, the company has evolved from its origins in construction to specialize in equipment sales and service. It operates across a vast area of over 191,000 square miles, including Idaho, Eastern Washington, Oregon, Western Montana, and Wyoming, with 17 branches and 15 Cat® Rental Stores. The company offers a range of services, including the sale of new and used heavy equipment, short- and long-term rentals of various machinery, and comprehensive maintenance and repair services. They provide genuine Cat® parts and accessories, ensuring quick sourcing and delivery. Western States Cat serves commercial and industrial clients, focusing on construction, mining, and infrastructure development, and emphasizes personalized service and tailored financing solutions for its customers.
The Federal Community Defender Office for the Eastern District of Pennsylvania, an office within the Defender Association of Philadelphia, is the designated Federal Community Defender Organization for the United States District Court for the Eastern District of Pennsylvania. Since its creation in 1972, the Federal Community Defender Office has been funded to render Defender Services to individuals who are unable to afford counsel and who are under investigation for, or charged with, violations of the laws of the United States, and to federal death-sentenced prisoners in Pennsylvania and elsewhere, when appointed. Upon appointment by the District Court or the Third Circuit Court of Appeals, the office provides representation for individuals who have been subpoenaed to appear before investigating Grand Juries, who are named defendants in criminal complaints, or who have been indicted by a Grand Jury. The representation, once undertaken, remains throughout the pendency of the proceedings, up to and including applications for relief to the Supreme Court of the United States. In addition, upon appointment, the office represents state and federal prisoners who are seeking relief by way of Habeas Corpus application in both the District Court and the Court of Appeals.
American Nuclear Insurers (ANI) is a joint underwriting association created by some of the largest insurance companies in the United States. Our purpose is to pool the financial assets pledged by our member companies to provide the significant amount of property and liability insurance required for nuclear power plants and related facilities throughout the world.
Fleetworx help the car fleet supply chain work better for everyone. We do this by combining data analytics with technology and expertise. Our specialist services help businesses deliver robust company car fleet management in the UK and across EMEA. We leverage data analytics to dramatically improve decision making and our expertise and practical influence spans the entire fleet supply chain. Our primary objective is to deliver savings, compliance and control and our focused and impartial approach is proven to deliver a significant return on investment. Savings - we provide client-side support in the design and delivery of cost-saving and carbon-saving company car policies. Compliance - we act as an extension of your business. Our robust Management Information System, Fleetworx Centrax, ensure you and your supply chain is fully compliant. Control - we impose tight control on all aspects of your company car fleet, creating a slick, cost-effective and valued reward and retention solution. Our services are particularly valued by fleet generalists in HR/procurement or finance roles who have company car fleet responsibility Contact us at sales@fleetworx.com or visit our website to read our thoughts on the fleet sector and learn more about how we help our clients.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.